Nurix Therapeutics, Inc. Q1 Loss increases, but beats estima

Nurix Therapeutics, Inc. (NRIX) announced Loss for its first quarter that increased from last year but beat the Street estimates. The company's bottom line came in at -$41.

Related Keywords

, Nurix Therapeutics Inc , Thomson Reuters , Nurix Therapeutics ,